Current Status and Strategy of Diagnosis and Treatment for Recurrent Hepatocellular Carcinoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

李波

Corresponding?author：

Keywords：

原發性肝細胞性肝癌; 復發肝癌; 診斷; 治療; 機制

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李波. Current Status and Strategy of Diagnosis and Treatment for Recurrent Hepatocellular Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2013, 20(5): 469-473. doi: Copy

1.	Llovet JM， Schwartz M， Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis， 2005， 25(2)：181-200.
2.	叢文銘，吳孟超. 肝癌術后復發發生機制及臨床病理學意義[J]. 中國實用外科雜志， 2012， 32(10)：809-811.
3.	Kim MY， Oskarsson T， Acharyya S， et al. Tumor self-seeding by circulating cancer cells[J]. Cell， 2009， 139(7)：1315-1326.
4.	Zhang Y， Li J， Cao L， et al. Circulating tumor cells in hepatocellular carcinoma：detection techniques， clinical implications， and future perspectives[J]. Semin Oncol， 2012， 39(4)：449-460.
5.	Portolani N， Coniglio A， Ghidoni S， et al. Early and late recurrence after liver resection for hepatocellular carcinoma：prognosticand therapeutic implications[J]. Ann Surg， 2006， 243(2)：229-235.
6.	孫建，簡志祥，區應亮，等. 肝癌根治性切除術后早期復發時限和模式的確定及其對預后的影響[J]. 實用醫學雜志， 2011， 27(10)：1748-1750.
7.	Poon RT， Fan ST， Ng IO， et al. Significance of resection marginin hepatectomy for hepatocellular carcinoma：A critical reappraisal[J]. Ann Surg， 2000， 231(4)：544-551.
8.	Kow AW， Kwon CH， Song S， et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma：review of 1 222 cases of hepatectomy in a tertiary institution[J]. Ann Surg Oncol， 2012， 19(7)：2246-2255.
9.	Burak KW. Prognosis in the early stages of hepatocellular carci-noma：Predicting outcomes and properly selecting patients forcurative options[J]. Can J Gastroenterol， 2011， 25(9)：482-484.
10.	Wu TH， Yu MC， Chen TC， et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma[J]. J Surg Oncol， 2012， 105(1)：85-90.
11.	Lee CW， Chan KM， Lee CF， et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis：clinicopathological analysis and survival outcome[J]. Asian J Surg， 2011， 34(2)：53-62.
12.	Ye JZ， Miao ZG， Wu FX， et al. Recurrence after anatomicresection versus nonanatomic resection for hepatocellular carcinoma：a meta-analysis[J]. Asian Pac J Cancer Prev， 2012， 13(5)：1771-1777.
13.	Poon RT， Fan ST， Lo CM， et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitisB-related cirrhosis[J]. J Clin Oncol， 2000， 18(5)：1094-1101.
14.	Tamura Y， Suda T， Arii S， et al. Value of highly sensitive fucos-ylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment[J]. Dig Dis Sci， 2013 Apr 18. [Epub ahead of print].
15.	Shirakawa H， Suzuki H， Shimomura M， et al. Glypican-3 expre-ssion is correlated with poor prognosis in hepatocellular carcinoma[J]. Cancer Sci， 2009， 100(8)：1403-1407.
16.	Chen IP， Ariizumi SI， Nakano M， et al. Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy[J]. J Gastroenterol， 2013 Mar 27. [Epub ahead of print].
17.	Ahn S， Hyeon J， Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy[J]. Gut Liver， 2013， 7(2)：206-212.
18.	Hyeon J， Ahn S， Lee JJ， et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma[J]. Dig Dis Sci， 2013 Mar 2. [Epub ahead of print].
19.	Zhong JH， Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma：A meta-analysis[J]. Hepatol Res， 2010， 40(10)：943-953.
20.	Peng BG， He Q， Li JP， et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Am J Surg， 2009， 198(3)：313-318.
21.	Nitta H， Beppu T， Imai K， et al. Adjuvant hepatic arterial infusionchemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion[J]. World J Surg， 2013， 37(5)：1034-1042.
22.	廖錦岐，袁波，程玉，等. 不同治療方法對肝癌術后復發的評價[J]. 中國醫藥科學， 2011， 19(1)：46-47.
23.	Lau WY， Lai EC. Hepatocellular carcinoma：current management and recent advances[J]. Hepatobiliary Pancreat Dis Int， 2008， 7(3)：237-257.
24.	Zhou YM， Sui CG， Li B， et al. Repeat hepatectomy for recurrent hepatocellular carcinoma：a local experience and a systematic review[J]. World J Surg Oncol， 2010， 8：55.
25.	Chan DL， Morris DL， Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma－A systematic review[J]. Surg Oncol， 2013， pii：S0960-7404(13)00027-3. doi：10.1016/j.suronc.2013.02.009.
26.	Hu Z， Wang W， Li Z， et al. Recipient outcomes of salvage liver transplantation versus primary liver transplantation：a systematic review and meta-analysis[J]. Liver Transpl， 2012， 18(11)：1316-1323.
27.	Liu F， Yuan D， Wei YG， et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk[J]. Plos One， 2012， 7(8)：1-10.
28.	方河清，唐酷，何敏志. 射頻消融在復發性肝癌治療中的應用[J]. 肝膽外科雜志， 2012， 20(4)：246-247.
29.	區應亮，孫建，王慧玲，等. 肝癌根治性切除術后早期復發的治療策略[J]. 廣東醫學， 2012， 33(5)：622-625.

1. Llovet JM， Schwartz M， Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis， 2005， 25(2)：181-200.
2. 叢文銘，吳孟超. 肝癌術后復發發生機制及臨床病理學意義[J]. 中國實用外科雜志， 2012， 32(10)：809-811.
3. Kim MY， Oskarsson T， Acharyya S， et al. Tumor self-seeding by circulating cancer cells[J]. Cell， 2009， 139(7)：1315-1326.
4. Zhang Y， Li J， Cao L， et al. Circulating tumor cells in hepatocellular carcinoma：detection techniques， clinical implications， and future perspectives[J]. Semin Oncol， 2012， 39(4)：449-460.
5. Portolani N， Coniglio A， Ghidoni S， et al. Early and late recurrence after liver resection for hepatocellular carcinoma：prognosticand therapeutic implications[J]. Ann Surg， 2006， 243(2)：229-235.
6. 孫建，簡志祥，區應亮，等. 肝癌根治性切除術后早期復發時限和模式的確定及其對預后的影響[J]. 實用醫學雜志， 2011， 27(10)：1748-1750.
7. Poon RT， Fan ST， Ng IO， et al. Significance of resection marginin hepatectomy for hepatocellular carcinoma：A critical reappraisal[J]. Ann Surg， 2000， 231(4)：544-551.
8. Kow AW， Kwon CH， Song S， et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma：review of 1 222 cases of hepatectomy in a tertiary institution[J]. Ann Surg Oncol， 2012， 19(7)：2246-2255.
9. Burak KW. Prognosis in the early stages of hepatocellular carci-noma：Predicting outcomes and properly selecting patients forcurative options[J]. Can J Gastroenterol， 2011， 25(9)：482-484.
10. Wu TH， Yu MC， Chen TC， et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma[J]. J Surg Oncol， 2012， 105(1)：85-90.
11. Lee CW， Chan KM， Lee CF， et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis：clinicopathological analysis and survival outcome[J]. Asian J Surg， 2011， 34(2)：53-62.
12. Ye JZ， Miao ZG， Wu FX， et al. Recurrence after anatomicresection versus nonanatomic resection for hepatocellular carcinoma：a meta-analysis[J]. Asian Pac J Cancer Prev， 2012， 13(5)：1771-1777.
13. Poon RT， Fan ST， Lo CM， et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitisB-related cirrhosis[J]. J Clin Oncol， 2000， 18(5)：1094-1101.
14. Tamura Y， Suda T， Arii S， et al. Value of highly sensitive fucos-ylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment[J]. Dig Dis Sci， 2013 Apr 18. [Epub ahead of print].
15. Shirakawa H， Suzuki H， Shimomura M， et al. Glypican-3 expre-ssion is correlated with poor prognosis in hepatocellular carcinoma[J]. Cancer Sci， 2009， 100(8)：1403-1407.
16. Chen IP， Ariizumi SI， Nakano M， et al. Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy[J]. J Gastroenterol， 2013 Mar 27. [Epub ahead of print].
17. Ahn S， Hyeon J， Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy[J]. Gut Liver， 2013， 7(2)：206-212.
18. Hyeon J， Ahn S， Lee JJ， et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma[J]. Dig Dis Sci， 2013 Mar 2. [Epub ahead of print].
19. Zhong JH， Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma：A meta-analysis[J]. Hepatol Res， 2010， 40(10)：943-953.
20. Peng BG， He Q， Li JP， et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Am J Surg， 2009， 198(3)：313-318.
21. Nitta H， Beppu T， Imai K， et al. Adjuvant hepatic arterial infusionchemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion[J]. World J Surg， 2013， 37(5)：1034-1042.
22. 廖錦岐，袁波，程玉，等. 不同治療方法對肝癌術后復發的評價[J]. 中國醫藥科學， 2011， 19(1)：46-47.
23. Lau WY， Lai EC. Hepatocellular carcinoma：current management and recent advances[J]. Hepatobiliary Pancreat Dis Int， 2008， 7(3)：237-257.
24. Zhou YM， Sui CG， Li B， et al. Repeat hepatectomy for recurrent hepatocellular carcinoma：a local experience and a systematic review[J]. World J Surg Oncol， 2010， 8：55.
25. Chan DL， Morris DL， Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma－A systematic review[J]. Surg Oncol， 2013， pii：S0960-7404(13)00027-3. doi：10.1016/j.suronc.2013.02.009.
26. Hu Z， Wang W， Li Z， et al. Recipient outcomes of salvage liver transplantation versus primary liver transplantation：a systematic review and meta-analysis[J]. Liver Transpl， 2012， 18(11)：1316-1323.
27. Liu F， Yuan D， Wei YG， et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk[J]. Plos One， 2012， 7(8)：1-10.
28. 方河清，唐酷，何敏志. 射頻消融在復發性肝癌治療中的應用[J]. 肝膽外科雜志， 2012， 20(4)：246-247.
29. 區應亮，孫建，王慧玲，等. 肝癌根治性切除術后早期復發的治療策略[J]. 廣東醫學， 2012， 33(5)：622-625.

Next Article
從汶川至蘆山：地震醫療救援投入產出效益評估

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Current Status and Strategy of Diagnosis and Treatment for Recurrent Hepatocellular Carcinoma

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content